Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women.
- P. Mink, C. Scrafford, D. Jacobs
- MedicineAmerican Journal of Clinical Nutrition
- 1 March 2007
Dietary intakes of flavanones, anthocyanidins, and certain foods rich in flavonoids were associated with reduced risk of death due to CHD, CVD, and all causes.
Prospective study of diet and ovarian cancer.
- L. Kushi, P. Mink, T. Sellers
- MedicineAmerican Journal of Epidemiology
- 1999
The association of epithelial ovarian cancer with dietary factors in a prospective study of 29,083 postmenopausal women is investigated, generally in agreement with the results from previous, mostly case-control studies of diet and epithelial Ovarian cancer.
Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women.
- L. Kushi, A. Folsom, R. Prineas, P. Mink, Y. Wu, R. Bostick
- MedicineNew England Journal of Medicine
- 2 May 1996
Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study.
- A. Folsom, L. Kushi, R. Prineas
- MedicineArchives of Internal Medicine
- 24 July 2000
The waist-hip ratio was the best anthropometric predictor of total mortality and was associated less consistently than BMI or waist circumference with cancer incidence, and all anthropometric indexes were associated with incidence of diabetes and hypertension.
The non‐Hodgkin lymphomas: A review of the epidemiologic literature
- D. Alexander, P. Mink, D. Trichopoulos
- MedicineInternational Journal of Cancer
- 2007
The non‐Hodgkin lymphomas (NHL) are a heterogeneous group of B‐cell and T‐cell neoplasms that arise primarily in the lymph nodes that appear to be associated with differing types of HIV and other infectious agents.
Multiple myeloma: A review of the epidemiologic literature
- D. Alexander, P. Mink, D. Trichopoulos
- MedicineInternational Journal of Cancer
- 2007
Evaluated epidemiologic studies evaluated lifestyle, dietary, occupational and environmental factors; immune function, family history and genetic factors; and the hypothesized precursor, monoclonal gammopathies of undetermined significance (MGUS), which found no established risk factors for MGUS.
Menopausal hormone replacement therapy and risk of ovarian cancer
- J. Lacey, P. Mink, C. Schairer
- Medicine, BiologyJAMA
- 17 July 2002
Women who used estrogen-only replacement therapy, particularly for 10 or more years, were at significantly increased risk of ovarian cancer in this study.
Probabilities of death from breast cancer and other causes among female breast cancer patients.
- C. Schairer, P. Mink, L. Carroll, S. Devesa
- MedicineJournal of the National Cancer Institute
- 1 September 2004
The probability of death from breast cancer versus other causes varied substantially according to stage, tumor size, ER status, and age at diagnosis in both white and black patients.
Dietary flavonoid intake and risk of cancer in postmenopausal women: The Iowa Women's Health Study
- Gretchen J. Cutler, J. Nettleton, K. Robien
- MedicineInternational Journal of Cancer
- 1 August 2008
Support is provided for a beneficial effect of flavonoid intake on lung cancer risk, especially among current and past smokers.
Physical activity and mortality in postmenopausal women.
- L. Kushi, R. Fee, A. Folsom, P. Mink, K. Anderson, T. Sellers
- MedicineJAMA
- 23 April 1997
These results demonstrate a graded, inverse association between physical activity and all-cause mortality in postmenopausal women and strengthen the confidence that population recommendations to engage in regular physical activity are applicable to post menopausal women.
...
...